BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers — Stella

Home/Diabetic Foot Ulcer/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Foot Ulcer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Taiwan

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, Taipei

Key details

Phase

Safety & dosing

Sponsor

Blue Blood Biotech Corp.

Enrollment target

~96 participants

Started

May 2024

Primary completion

December 2027

Age range

20 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.